Valerian for Conscious Sedation in Patients Submitted to Impacted Lower Third Molars Surgery

Federal University of the Valleys of Jequitinhonha and Mucuri

Status

Completed

Conditions

Dental Anxiety

Heart Rate

Blood Pressure

Treatments

Drug: Placebo 100mg

Drug: 100 mg of Valeriana officinalis L

Study type

Interventional

Funder types

Other

Identifiers

NCT01612130

098/2002

Details and patient eligibility

About

The aim of the present study was to evaluate the efficacy of Valeriana officinalis L. 100 mg in single oral doses one hour preoperative as conscious sedation during the impacted lower third molar surgery.

Full description

Evaluate the efficacy of Valeriana officinalis L. (Valerian) for control of anxiety during third molar surgery. Study design: A single oral dose of either valerian (100 mg) or placebo was randomly administered one hour before each surgical procedure to 20 volunteers between 17 and 31 years of age. Anxiety level was assessed through questionnaires, physiological parameters (blood pressure and heart rate) and the observation of signs.

Enrollment

20 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Indication for bilateral extraction of asymptomatic impacted mandibular third molars in similar positions based on the Pell & Gregory classification

Exclusion criteria

Use of any type of medication in the 15 days prior to the onset of the study; history of hypersensitivity to the drugs, substances or materials employed in the experiment; pregnancy or lactation